FK 409
Alternative Names: FR 900409; FR 900411Latest Information Update: 17 Apr 2002
At a glance
- Originator Fujisawa; Nonindustrial source
- Class Antiplatelets; Heart failure therapies; Ischaemic heart disorder therapies; Small molecules; Vasodilators
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart transplant rejection; Lung transplant rejection; Peptic ulcer; Renal failure
- Discontinued Angina pectoris; Heart failure; Hypertension; Thrombosis